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Abstract
Genome-wide association studies (GWAS) have emerged as a rich source of genetic
clues into disease biology, and they have revealed strong genetic correlations
among many diseases and traits. Some of these genetic correlations may reflect
causal relationships. We developed a method to quantify causal relationships
between genetically correlated traits using GWAS summary association statistics.
In particular, our method quantifies what part of the genetic component of trait 1 is
also causal for trait 2 using mixed fourth moments E(α21α1α2) and E(α
2
2α1α2)
of the bivariate effect size distribution. If trait 1 is causal for trait 2, then SNPs
affecting trait 1 (large α21) will have correlated effects on trait 2 (large α1α2), but
not vice versa. We validated this approach in extensive simulations. Across 52 traits
(average N = 331k), we identified 30 putative genetically causal relationships,
many novel, including an effect of LDL cholesterol on decreased bone mineral
density. More broadly, we demonstrate that it is possible to distinguish between
genetic correlation and causation using genetic association data.
This manuscript is an abridged version of O’Connor and Price 2018 Nature Genetics1.
Genome-wide association studies (GWAS) have identified thousands of common genetic variants
(SNPs) affecting disease risk and other complex traits.2–6 The same SNPs often affect multiple traits,
resulting in a genetic correlation: genetic effect sizes are correlated across the genome, and so are the
traits themselves.7–10 Some genetic correlations may result from causal relationships. For example,
SNPs that cause higher triglyceride levels reliably confer increased risk of coronary artery disease.11
This causal inference approach, using genetic variants as instrumental variables,12, 13 is known as
Mendelian Randomization (MR).14–16 However, genetic variants often have shared, or “pleiotropic”,
effects on multiple traits even in the absence of a causal relationship, and pleiotropy is a challenge
for MR, especially when it leads to a strong genetic correlation.8–10, 14, 16 Statistical methods have
been used to account for certain kinds of pleiotropy;9, 10, 17–20 however, these approaches too are
easily confounded by genetic correlations due to pleiotropy. Here, we develop a robust method to
distinguish whether a genetic correlation results from pleiotropy or from causality.
1 Latent causal variable model
The latent causal variable (LCV) model features a latent variable L that mediates the genetic correla-
tion between the two traits (Figure 1a). More abstractly, L represents the shared genetic component
of both traits. Trait 1 is fully genetically causal for trait 2 if it is perfectly genetically correlated with
L; “fully” means that the entire genetic component of trait 1 is causal for trait 2 (Figure 1b). More
generally, trait 1 is partially genetically causal for trait 2 if the latent variable has a stronger genetic
correlation with trait 1 than with trait 2; “partially” means that part of the genetic component of trait 1
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Figure 1: Illustration of the latent causal variable model. We display the relationship between
genotypes X , latent causal variable L and trait values Y1 and Y2. (a) General case of the model. (b)
Special case of full genetic causality: when q1 = 1, the genetic component of Y1 is equal to L.
is causal for trait 2. In equations, Y1 and Y2 are modeled as linear functions of the genotype vector,
X , and uncorrelated noise,  (a linear model is appropriate, due to the small effect sizes of individual
variants):
Y1 = q1Xpi +Xγ1 + 1, Y2 = q2Xpi +Xγ2 + 2. (1)
where qk is a scalar representing the effect ofL on trait k,Xpi represents the shared genetic component
L, and γkX represents the trait-specific genetic component of trait k (see Figure 1). In order to
quantify partial causality, we define the genetic causality proportion (gcp) of trait 1 on trait 2. The
gcp is defined as the number x such that:
q22/q
2
1 = (ρ
2)x, (2)
where ρ = q1q2 is the genetic correlation.8 The gcp ranges from −1 to 1. When it is positive, q1 is
greater than q2, and trait 1 is partially genetically causal for trait 2. When it is equal to 1, q1 is equal
to one, Y1 is fully genetically correlated with L, and trait 1 is fully genetically causal. When it is 0,
there is no partial causality; L explains the same proportion of heritability for both traits. A high value
of gcp implies that interventions targeting trait 1 are likely to affect trait 2, and an intermediate value
implies that some interventions targeting trait 1 may affect trait 2, depending on their mechanism of
action. However, we caution that an intervention may fail to mimic genetic perturbations, e.g. due to
its timing relative to disease progression.
The LCV model makes one fundamental assumption, that the bivariate effect size distribution (α1, α2)
is a sum of two independent distributions: (1) a shared genetic component (q1pi, q2pi), whose values
are proportional for both traits; and (2) a trait-specific distribution (γ1, γ2) whose density is mirror
symmetric across both axes (i.e., (γ1, γ2) ∼ (−γ1, γ2) ∼ (γ1,−γ2)). This assumption is much
weaker than the “exclusion restriction" assumption of MR;16 in particular, the LCV model permits
both correlated pleiotropic effects (mediated by L) and uncorrelated pleiotropic effects (not mediated
by L), while the exclusion restriction assumption permits neither. Linkage disequilibrium (LD) is not
central to the model, but this assumption pertains to the marginal effect size distribution (inclusive of
LD). This model and the ways it could be violated are discussed in greater detail in the Appendix.
2 Inference using fourth moments
In order to test for partial genetic causality and to estimate the gcp, we compare the mixed fourth
moments E(α21α1α2) and E(α
2
2α1α2) of the marginal SNP-effect-size distribution. The rationale for
utilizing these mixed fourth moments is that if trait 1 is causal for trait 2, then SNPs with large effects
on trait 1 (i.e. large α21) will have proportional effects on trait 2 (large α1α2), so that E(α
2
1α1α2)
will be large; conversely, SNPs with large effects on trait 2 (large α22) will generally not affect trait 1
(small α1α2), so that E(α22α1α2) will not be as large. Thus, estimates of the mixed fourth moments
can be used to test for partial genetic causality and to estimate the gcp.
2
In particular, we utilize the following relationship between the mixed fourth moments and the
parameters q1 and q2 (Figure 1; see Appendix for derivation):
E(α31α2) = κpiq
3
1q2 + 3ρ, (3)
where pi is the effect of a SNP on L and κpi = E(pi4)− 3 is the excess kurtosis of pi. This equation
implies that if E(α31α2)
2 ≥ E(α1α32)2, then q21 ≥ q22 . We note that when κpi = 0, and in particular
when pi follows a normal distribution, this equation is not useful for inference and the model is
unidentifiable.
We calculate statistics S(x) for each possible value of gcp = x, based on equation (3). These
statistics utilize estimates of the heritability and the genetic correlation,8, 21 in addition to the mixed
fourth moments. We estimate the variance of these statistics using a block jackknife and obtain an
approximate likelihood function for the gcp. We compute a posterior mean estimate of gcp (and
a posterior standard deviation) using a uniform prior on [−1, 1]. We test the null hypothesis (that
gcp = 0) using the statistic S(0). Further details of the method are provided in the Appendix.
Open source implementations of the LCV method in Matlab and R are available at github.com/
lukejoconnor/LCV.
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Figure 2: Null simulations with no LD to assess calibration. We report the false positive rate
(α = 0.05) for a causal (or partially causal) effect. (a) Pleiotropic SNPs have uncorrelated effects
on the two traits (ρ = 0). (b) Pleiotropic SNPs have correlated effects on the two traits, resulting
in a genetic correlation (ρ = 0.2). (c) Trait-specific SNPs have unequal polygenicity (4× different)
between the two traits (ρ = 0.2). (d) The two traits have unequal sample size (5× different; ρ = 0.2).
0
0.5
1
Po
s r
at
e 
(
=0
.0
01
)
(a) Default parameters
0
0.5
1
(b) High/low N1
0
0.5
1
(c) High/low N2
0 2 4
0
2
4
MR
MR-Egger
Bi-MR
LCV
Figure 3: Causal simulations with no LD to assess power. We report true the positive rate (α = 0.001)
for a (partially) causal effect. (a) Causal simulations with default parameters. (b) Higher (unfilled) or
lower (filled) sample size for trait 1. (c) Higher (unfilled) or lower (filled) sample size for trait 2.
3 Simulations
To compare LCV with existing causal inference methods, we performed simulations involving
simulated GWAS summary statistics with no LD. We compared four main methods: LCV, random-
effect two-sample MR22 (denoted MR), MR-Egger,17 and Bidirectional MR.9 We applied each
method to simulated GWAS summary statistics for two traits, testing for causality.
We compared the false positive rate of LCV and MR in null simulations (gcp = 0) with pleiotropy.
There were N = 100k samples, M = 50k SNPs, and heritability h2 = 0.3. First, we performed
simulations with uncorrelated pleiotropic effects (via γ1, γ2; see Figure 1a) and zero genetic cor-
relation. All four methods produced well-calibrated or conservative p-values (Figure 2a). Second,
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we performed null simulations with a nonzero genetic correlation (ρ = 0.2). MR and MR-Egger
both exhibited severely inflated false positive rates; in contrast, Bidirectional MR and LCV produced
well-calibrated p-values (Figure 2b). Third, we performed null simulations with a nonzero genetic
correlation and differential polygenicity in the non-shared genetic architecture between the two traits.
Because causal SNPs affecting trait 1 only had larger effect sizes than SNPs affecting trait 2 only, they
were more likely to be genome-wide significant, and as a result, Bidirectional MR (and other MR
methods) exhibited inflated false positive rates. In contrast, LCV produced well-calibrated p-values
(Figure 2c). Fourth, we performed null simulations with a nonzero genetic correlation and unequal
sample size for the two traits, reducing the sample size from 100k to 20k for trait 2. The MR methods,
including bidirectional MR, exhibited inflated false positive rates, unlike LCV (Figure 2d).
We sought to compare the power of LCV and MR to detect a causal effect in simulations with
full genetic causality (gcp = 1). First, we performed causal simulations with reduced sample size
(N = 25k), and a causal effect size of q2 = 0.2. LCV and MR were well-powered to detect a causal
effect, while Bidirectional MR and MR-Egger had lower power. Second, we reduced the sample
size for trait 1 (Figure 9.3b), finding that LCV had high power while the MR methods had very low
power, owing to the small number of genome-wide significant SNPs. Third, we reduced the sample
size for trait 2 (Figure 9.3c). LCV and MR had high power, while Bidirectional MR and MR-Egger
had lower power.
Simulations involving LCV model violations and LD are described in the Appendix. We conclude
that MR methods, including methods that purportedly account for pleiotropy, are easily confounded.
In contrast, LCV is well-calibrated and well-powered across diverse genetic architectures.
4 Results on 52 diseases and complex traits
We applied LCV and the MR methods to GWAS summary statistics for 52 diseases and complex
traits, including 37 from UK Biobank23–25 (average N = 337k; see Table 1 in Appendix). 429 trait
pairs (32%) had a nominally significant genetic correlation (p < 0.05). We applied LCV to these
trait pairs and detected significant evidence of full or partial genetic causality for 59 trait pairs (FDR
< 1%), including 30 trait pairs with ˆgcp > 0.6 (Table 2 in Appendix).
Myocardial infarction (MI) had a nominally significant genetic correlation with 31 other traits, of
which six had significant evidence for a fully or partially genetically causal effect on MI (Table 2 in
Appendix). Consistent with previous studies, these traits included LDL and high cholesterol,15, 26
triglycerides11 and BMI,27 but not HDL.15 We also detected evidence for a fully or partially genetically
causal effect of hypothyroidism; such an effect is mechanistically plausible.28, 29
We detected evidence for a negative genetically causal effect of LDL on bone mineral density
(BMD; Table 2). This result is consistent with preliminary clinical evidence,30 and familial defective
apolipoprotein B leads to high LDL cholesterol and low bone mineral density.31 Larger clinical trials
of LDL lowering for individuals at risk of osteoporosis may be warranted, although we caution that
the effect size is not expected to be large.
In order to evaluate whether the limitations of MR observed in simulations are also observed in
analyses of real traits, we applied MR to all 429 genetically correlated trait pairs. MR reported
significant causal relationships (1% FDR) for 271/429 trait pairs, including 155 pairs of traits for
which each trait was reported to be causal for the other. This implausible result confirms that MR
frequently produces false positives due to genetic correlations, consistent with simulations (Figure 2).
Our method represents an advance for two main reasons. First, LCV reliably distinguishes between
genetic correlation and causation. Unlike existing methods, LCV produces well-calibrated false
positive rates in null simulations and plausible results on real data. Second, we define and estimate
the genetic causality proportion (gcp) to quantify the degree of causality non-dichotomously. We
found that 29/59 significant trait pairs had gcp estimates below 0.6; these trait pairs, while potentially
interesting, probably do not reflect fully causal relationships. However, an important limitation of
this study is that it models only two traits and only one latent variable; it cannot be used to perform
conditional analyses with multiple traits, and it may miss causal effects when additional shared
pathways also contribute to the genetic correlation. Nonetheless, we anticipate that LCV will be
widely used as genetic association data becomes available for increasing numbers of diseases and
potentially causal traits.
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Appendix
5 Tables
7
Phenotype Reference N (thousands) Zh
Anorexia Boraska et al., 2014 Mol Psych 32 17.8
Autism Spectrum PGC Cross-Disorder Group, 2013 Lancet 10 12.1
Bipolar Disorder BIP Working Group of the PGC, 2011 Nat Genet 17 11.8
Breast Cancer Amos et al., 2016 Cancer Epidemiol. Biomarkers Prev. ∼ 447* 16
Celiac Disease Dubois et al., 2010 Nat Genet 15 10.4
Crohns Disease Jostins et al., 2012 Nature 21 12.1
Depressive symptoms Okbay et al., 2016 Nat Genet 161 13.1
HDL Teslovich et al., 2010 Nature 98 8.2
HbA1c Soranzo et al., 2010 Diabetes 46 8.8
LDL Teslovich et al., 2010 Nature 93 8.1
Lupus Bentham et al., 2015 Nat Genet 14 10.2
Prostate Cancer Amos et al., 2016 Cancer Epidemiol. Biomarkers Prev. ∼ 447* 7.5
Schizophrenia SCZ Working Group of the PGC, 2014 Nature 70 17.4
Triglycerides Teslovich et al., 2010 Nature 94 9.5
Ulcerative Colitis Jostins et al., 2012 Nature 27 8.8
Eosinophil count UK Biobank 23–25 ∼ 460** 20.8
Reticulocyte count UK Biobank 23–25 ∼ 460 19.9
Lymphocyte count UK Biobank 23–25 ∼ 460 22.7
Mean corpuscular hemoglobin UK Biobank 23–25 ∼ 460 14.3
Mean platelet volume UK Biobank 23–25 ∼ 460 15.7
Monocyte count UK Biobank 23–25 ∼ 460 15.1
Platelet count UK Biobank 23–25 ∼ 460 20.2
Platelet distribution width UK Biobank 23–25 ∼ 460 17.1
RBC distribution width UK Biobank 23–25 ∼ 460 19.7
RBC count UK Biobank 23–25 ∼ 460 17.5
White cell count UK Biobank 23–25 ∼ 460 20.7
Bone mineral density - heel UK Biobank 23–25 ∼ 460 29
Balding - male*** UK Biobank 23–25 ∼ 230 16.1
BMI UK Biobank 23–25 ∼ 460 27.5
Height UK Biobank 23–25 ∼ 460 24.7
BP - diastolic UK Biobank 23–25 ∼ 460 32.3
BP - systolic UK Biobank 23–25 ∼ 460 28.3
College UK Biobank 23–25 ∼ 460 19.1
Smoking status UK Biobank 23–25 ∼ 460 24.9
Eczema UK Biobank 23–25 ∼ 460 21.8
Asthma UK Biobank 23–25 ∼ 460 16.8
Dermatology UK Biobank 23–25 ∼ 460 9.1
Myocardial infarction UK Biobank 23–25 ∼ 460 18.6
High cholesterol UK Biobank 23–25 ∼ 460 15.6
Hypertension UK Biobank 23–25 ∼ 460 36.2
Hypothyroidism UK Biobank 23–25 ∼ 460 20.1
Type 2 Diabetes UK Biobank 23–25 ∼ 460 19.5
Basal metabolic rate UK Biobank 23–25 ∼ 460 23.4
FEV1/FVC UK Biobank 23–25 ∼ 460 17.7
FVC UK Biobank 23–25 ∼ 460 18.8
Neuroticism UK Biobank 23–25 ∼ 460 28.7
Morning person UK Biobank 23–25 ∼ 460 21.1
Age at menarche UK Biobank 23–25 ∼ 230 24
Age at menopause UK Biobank 23–25 ∼ 230 19.1
Number children - female UK Biobank 23–25 ∼ 230 14.4
Number children - male UK Biobank 23–25 ∼ 230 15.1
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Table 1: 52 GWAS datasets included in the analysis. Most UK Biobank summary
statistics are publicly available.25 All datasets have heritability Z-score Zh > 7
and estimated genetic correlation ρˆg < 0.9 with other traits. Summary statistics
for ∼ 1, 000, 000 HapMap3 SNPs were used, excluding the MHC region. *Total
number of samples genotyped by OncoArray; actual sample size is slightly less
than 447k. These numbers are excluded from average reported sample size for
non-UK Biobank traits. **Actual sample size for UK Biobank analyses is slightly
less than 460k (respectively 230k for sex-specific traits), owing to incomplete
phenotype data. For most case control traits, effective sample size is substantially
less than 460k due to the low fraction of cases. ***The balding phenotype was the
“balding 4" UK Biobank category, corresponding to nearly-complete baldness.
Trait 1 Trait 2 pLCV ρˆg (std err) ˆgcp(std err) paux MR ref
Triglycerides Hypertension 5× 10−39 0.25 (0.04) 0.95 (0.04) 0.04
BMI Myocardial infarction 3× 10−9 0.34 (0.09) 0.94 (0.11) 0.22 33, 34
Triglycerides Myocardial infarction 8× 10−32 0.30 (0.06) 0.90 (0.08) 0.04 11
Triglycerides BP - systolic 6× 10−41 0.13 (0.03) 0.89 (0.08) 8× 10−4
HDL Hypertension 6× 10−22 -0.29 (0.06) 0.87 (0.09) 0.15
LDL High cholesterol 8× 10−7 0.77 (0.07) 0.86 (0.11) 0.08
Triglycerides Mean cell volume 10× 10−19 -0.20 (0.04) 0.86 (0.11) 2× 10−4
Triglycerides BP - diastolic 5× 10−39 0.11 (0.04) 0.86 (0.10) 0.004
Platelet volume Platelet count 6× 10−10 -0.66 (0.03) 0.84 (0.10) 0.18
BMI Hypertension 2× 10−16 0.38 (0.03) 0.83 (0.11) 0.06 9, 34
Triglycerides Platelet dist width 5× 10−17 0.19 (0.04) 0.81 (0.13) 7× 10−5
LDL BMD 4× 10−34 -0.12 (0.05) 0.80 (0.12) 0.02
BMI FVC 4× 10−13 -0.22 (0.03) 0.79 (0.17) 0.001 35
Triglycerides Reticulocyte count 2× 10−10 0.33 (0.05) 0.79 (0.14) 0.02
Triglycerides Eosinophil count 3× 10−17 0.14 (0.05) 0.75 (0.16) 0.001
Balding - male Num children - male 2× 10−30 -0.16 (0.05) 0.75 (0.13) 2× 10−4
HDL Platelet dist width 8× 10−17 -0.14 (0.04) 0.75 (0.16) 0.004
RBC dist width Type 2 Diabetes 3× 10−4 0.11 (0.03) 0.73 (0.19) 0.21
LDL Myocardial infarction 2× 10−31 0.17 (0.08) 0.73 (0.13) 6× 10−4 15, 26
Platelet dist width Platelet count 1× 10−7 -0.47 (0.04) 0.73 (0.15) 0.04
Hypothyroidism Type 2 Diabetes 2× 10−4 0.22 (0.05) 0.73 (0.29) 0.2
HDL Type 2 Diabetes 2× 10−7 -0.40 (0.06) 0.72 (0.17) 0.35
Hypothyroidism Myocardial infarction 6× 10−12 0.26 (0.05) 0.72 (0.16) 0.08
High cholesterol Myocardial infarction 2× 10−4 0.52 (0.12) 0.71 (0.19) 0.32
HDL BP - diastolic 4× 10−17 -0.12 (0.06) 0.70 (0.18) 0.005
Platelet dist width Reticulocyte count 1× 10−7 0.13 (0.04) 0.69 (0.20) 0.005
LDL College 1× 10−10 -0.13 (0.05) 0.68 (0.30) 0.35
Triglycerides Monocyte count 1× 10−4 0.14 (0.04) 0.67 (0.21) 0.09
Type 2 Diabetes Ulcerative Colitis 2× 10−5 -0.14 (0.07) 0.65 (0.23) 0.41
BMI Reticulocyte count 4× 10−5 0.39 (0.03) 0.64 (0.25) 10× 10−4
HDL FEV1/FVC 1× 10−13 -0.09 (0.04) 0.56 (0.08) 0.19
High cholesterol Neuroticism 2× 10−14 0.09 (0.03) 0.55 (0.19) 0.32
Triglycerides Basal metab rate 2× 10−8 0.08 (0.04) 0.55 (0.13) 0.25
Height BMD 3× 10−14 -0.09 (0.04) 0.50 (0.14) 2× 10−8
Triglycerides Height 3× 10−14 -0.10 (0.03) 0.45 (0.09) 0.15
HbA1C High cholesterol 5× 10−22 0.25 (0.06) 0.44 (0.16) 0.49
Age at menarche Height 7× 10−11 0.16 (0.04) 0.43 (0.10) 2× 10−5 9
High cholesterol Smoking status 5× 10−19 0.13 (0.03) 0.42 (0.02) 0.52
Reticulocyte count Hypertension 2× 10−4 0.27 (0.04) 0.41 (0.13) 0.75
BMI Asthma 4× 10−14 0.21 (0.03) 0.40 (0.27) 0.05 35
High cholesterol Monocyte count 4× 10−4 0.09 (0.03) 0.40 (0.15) 0.2
Height Basal metab rate 10× 10−9 0.57 (0.03) 0.39 (0.07) 0.006
Eczema FEV1/FVC 2× 10−15 -0.08 (0.03) 0.36 (0.10) 2× 10−5
Height College 3× 10−6 0.17 (0.03) 0.33 (0.10) 0.06 36
Prostrate cancer Hypothyroidism 10× 10−5 -0.12 (0.05) 0.30 (0.38) 0.19
Crohns Disease LDL 4× 10−13 -0.12 (0.06) 0.29 (0.15) 0.82
9
High cholesterol Type 2 Diabetes 4× 10−6 0.42 (0.05) 0.24 (0.30) 0.62
RBC count Monocyte count 8× 10−7 0.14 (0.05) 0.24 (0.46) 0.31
HbA1C BMI 7× 10−17 0.25 (0.05) 0.23 (0.35) 0.77
Basal metab rate Hypothyroidism 6× 10−21 0.11 (0.04) 0.21 (0.04) 0.04
Platelet dist width Corpuscular hemoglobin 5× 10−14 -0.06 (0.02) 0.15 (0.14) 0.08
Depressive syndrome Asthma 4× 10−4 0.21 (0.05) 0.14 (0.08) 0.37
BMI High cholesterol 2× 10−6 0.33 (0.06) 0.13 (0.12) 0.25
Age at menopause Depressive syndrome 2× 10−7 -0.27 (0.06) 0.12 (0.32) 0.41
White cell count BMI 7× 10−5 0.24 (0.03) 0.09 (0.16) 1
Asthma Lymphocyte count 2× 10−4 0.09 (0.04) 0.08 (0.19) 0.57
Num children - male Hypothyroidism 9× 10−11 0.18 (0.05) 0.03 (0.26) 0.87
College High cholesterol 2× 10−8 -0.23 (0.03) 0.01 (0.08) 0.34
RBC dist width High cholesterol 4× 10−4 0.11 (0.04) 0.00 (0.17) 0.35
Table 2: Pairs of traits with evidence of partial genetic causality. We restricted
to pairs of traits having a nominally significant genetic correlation (two-tailed
p < 0.05; 429 trait pairs) and reported all traits with strong evidence of partial
causality (1% FDR). Trait pairs are ordered so that trait 1 is genetically causal or
partially genetically causal for trait 2. We have provided references for each trait
pair with existing support in the MR literature that we are aware of. For some
trait pairs, there was strong evidence for partial causality but low and noisy gcp
estimates. This phenomenon may occur due to multiple intermediaries, which
can cause the estimated mixed fourth moments to have opposite signs. When this
occurs, the approximate likelihood function is sometimes bimodal, with no support
for any specific value of gcp (because there is no value of gcp that produces mixed
fourth moments of opposite signs). While this phenomenon appears to occur
for several traits with gcp estimates close to zero, there were no trait pairs with
statistically significant evidence that their mixed fourth moments had opposite
signs.
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6 LCV model
The LCV random effects model assumes that the distribution of marginal effect sizes for the two
traits can be written as the sum of two independent bivariate distributions (visualized in Figure
1c-e in orange and blue respectively): (1) a shared genetic component (q1pi, q2pi) whose values are
proportional for both traits; and (2) an even genetic component (γ1, γ2) whose density is mirror
symmetric across both axes. Distribution (1) resembles a line through the origin, and we interpret
its effects as being mediated by a latent causal variable (L) (Figure 1a); distribution (2) does not
contribute to the genetic correlation, and we interpret its effects as direct effects. Informally, the
LCV model assumes that any asymmetry in the shared genetic architecture arises from a genetic
component that is fully shared between the two traits.
In detail, the LCV model assumes that there exist scalars q1, q2, and a distribution (pi, γ1, γ2) such
that
(α1, α2) = (q1pi + q2pi) + (γ1, γ2), where pi ⊥ (γ1, γ2) and (γ1, γ2)∼(−γ1, γ2)∼(γ1,−γ2). (4)
Here αk is the random marginal effect (i.e. the correlation) of a SNP of trait k, pi interpreted as the
marginal effect of a SNP on L, and γk is interpreted as the non-mediated effect of a SNP on trait k.
α and pi (but not γ) are normalized to have unit variance, and all random variables have zero mean.
(The symbol “∼” means “has the same distribution as.”) q1, q2 are the model parameters of primary
interest, and we can relate them to the mixed fourth moments, which are observable (equation (3)). In
particular, this implies that the model is identifiable (except when the excess kurtosis κpi = 0). Note
that we have avoided assuming a particular parametric distribution.
The LCV model assumptions are strictly weaker than the assumptions made by MR. Like LCV,
a formulation of the MR assumptions is that the bivariate distribution of SNP effect sizes can be
expressed in terms of two distributions. In particular, it assumes that the effect size distribution is a
mixture of (1’) a distribution whose values are proportional for both traits (representing all SNPs that
affect the exposure Y1) and (2’) a distribution with zero values for the exposure Y1 (representing
SNPs that only affect the outcome Y2). These two distributions can be compared with distributions
(1) and (2) above. Because (1’) is identical to (1) and (2’) is a special case of (2), the LCV model
assumptions are strictly weaker than the MR assumptions (indeed, much weaker). We also note that
the MR model is commonly illustrated with a non-genetic confounder affecting both traits. Our latent
variable L is a genetic variable, and it is not analogous to the non-genetic confounder. Similar to
MR, LCV is unaffected by nongenetic confounders (such a confounder may result in a phenotypic
correlation that is unequal to the genetic correlation).
The genetic causality proportion (gcp) is defined as:
gcp :=
log |q2| − log |q1|
log |q2|+ log |q1| , (5)
which satisfies
q22
q21
= (ρ2g)
gcp, (6)
where the genetic correlation ρg is equal to q1q2. gcp is positive when trait 1 is partially genetically
causal for trait 2. When gcp = 1, trait 1 is fully genetically causal for trait 2: q1 = 1 and the causal
effect size is q2 = ρg (Figure 1b,e). The LCV model is broadly related to dimension reduction
techniques such as Factor Analysis37 and Independent Components Analysis,38 although it differs in
its modeling assumptions as well as its goal (causal inference); our inference strategy (mixed fourth
moments) also differs.
Under the LCV model assumptions, we derive equation (3) as follows:
E(α31α2) =E((γ1 + q1pi)
3(γ2 + q2pi))
=q31q2E(pi
4) + 3q1q2E(pi
2γ21)
=q31q2E(pi
4) + 3q1q2E(pi
2)E(γ21)
=q31q2E(pi
4) + 3q1q2(1)(1− q21)
=q31q2(E(pi
4)− 3) + 3q1q2. (7)
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In the second line, we used the independence assumption to discard cross-terms of the form γppi3
and γ31pi, and we used the symmetry assumption to discard terms of the form γ1γ
3
2 . In the third and
fourth lines, we used the independence assumption, which implies that E(γ21pi
2) = E(γ21)E(pi
2) =
E(γ21) = 1− q21 . The factor E(pi4)− 3 is the excess kurtosis of pi, which is zero when pi follows a
Gaussian distribution; in order for equation (3) to be useful for inference, E(pi4)−3 must be nonzero,
and in order for the model to be identifiable, pi must be non-Gaussian.
7 Estimation under the LCV model
In order to estimate the gcp and to test for partial causality, we utilize six steps. First, we use LD
score regression21 to estimate the heritability of each trait; these estimates are used to normalize
the summary statistics. Second, we apply cross-trait LD score regression8 to estimate the genetic
correlation; the intercept in this regression is also used to correct for possible sample overlap when
estimating the mixed fourth moments. Third, we estimate the mixed fourth moments E(α1α32) and
E(α31α2) of the bivariate effect size distribution. Fourth, we compute test statistics for each possible
value of the gcp, based on the estimated genetic correlation and on the estimated mixed fourth
moments. Fifth, we jackknife on these test statistics to estimate their standard errors, similar to ref.
21, obtaining a likelihood function for the gcp. Sixth, we obtain posterior means and standard errors
for the gcp using this likelihood function and a uniform prior distribution. These steps are detailed
below.
First, we apply LD score regression to normalize the test statistics. Under the LCV model, the
marginal effect sizes for each trait, α1 and α2, have unit variance. We use a slightly modified version
of LD score regression,21 with LD scores computed from UK10K data.39 In particular, we run LD
score regression using a slightly different weighting scheme, matching the weighting scheme in our
mixed fourth moment estimators; the weight of SNP i was:
wi := max(1, 1/`
HapMap
i ), (8)
where `HapMapi was the estimated LD score between SNP i and other HapMap3 SNPs (this is approxi-
mately the set of SNPs that were used in the regression). This weighting scheme is motivated by the
fact that SNPs with high LD to other regression SNPs will be over-counted in the regression (see
ref. 21). Similar to ref. 8, we improve power by excluding large-effect variants when computing
the LD score intercept; for this study, we chose to exclude variants with χ2 statistic 30× the mean
(but these variants are not excluded when computing χ¯2). Then, we divide the summary statistics by
s =
√
χ¯2 − σˆ2 , where χ¯2 is the weighted mean χ2 statistic and σˆ2 is the LD score intercept. (We
also divide the LD score intercept by s2.) We assess the significance of the heritability by performing
a block jackknife on s, defining the significance Zh as s divided by its estimated standard error.
Second, to estimate the genetic correlation, we apply cross-trait LD score regression.8 Similar to
above, we use a slightly modified weighting scheme (equation (8)), and we exclude large-effect
variants when computing the cross-trait LD score intercept. We assess the significance of the genetic
correlation using a block jackknife.
Third, we estimate the mixed fourth moments E(α1α32) using the following estimation equation:
E(a1a
3
2|α1, α2) =α1α32 + E(132) + 3E(α1α222) + E(α2212)
=α1α
3
2 + 3E(12)E(
2
2) + 3α1α2E(
2
2) + α
2
2E(12)
=α1α
3
2 + 3σˆ12 σˆ
2
2 + 3α1α2σˆ
2
2 + α
2
2σˆ12 , (9)
where E(2k) is the LD score regression intercept for trait k and σˆ12 is the cross-trait LD score
regression intercept. For simulations with no LD, we use E(2k) = 1/sNk and E(12) = 0 instead
of estimating these values.
Fourth, we define a collection of statistics S(x) for x ∈ X = {−1,−.01,−.02, ..., 1} (corresponding
to possible values of gcp):
S(x) :=
A(x)−B(x)
max(1/|ρˆg|,
√
A(x)2 +B(x)2)
A(X) = |ρg|−xkˆ1, B(x) = |ρg|xkˆ2, (10)
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The motivation for utilizing the normalization by
√
A(x)2 +B(x)2 is that the magnitude ofA(x) and
B(x) tend to be highly correlated, leading to increased standard errors if we only use the numerator of
S. However, the denominator tends to zero when the genetic correlation is zero, leading to instability
in the test statistic and false positives. The use of the threshold leads to conservative, rather than
inflated, standard errors when the genetic correlation is zero or nearly zero. We recommend only
analyzing trait pairs with a significant genetic correlation, and this threshold usually has no effect on
the results. It is also inadvisable to analyze trait pairs whose genetic correlation is non-significant
because for positive LCV results, the genetic correlation provides critical information about the causal
effect size and direction.
Fifth, we estimate the variance of S(x) using a block jackknife with k = 100 blocks of contiguous
SNPs, resulting in minimal non-independence between blocks. Blocks are chosen to include the same
number of SNPs, and the jackknife standard error is
σˆS(x) =
√√√√101 100∑
j=1
(Sj(x)− S¯(x))2 (11)
where Sj(x) is the test statistic computed on blocks 1, ..., j− 1, j+ 1, ...100 and S¯(x) is the mean of
the jackknife estimates. We compute an approximate likelihood, L(S|gcp = x), by assuming (1) that
L(S|gcp = x) = L(S(x)|gcp = x) and (2) that if gcp = x then S(x)/σˆS(x) follows a T distribution
with 98 degrees of freedom.
Sixth, we impose a uniform prior on gcp, enabling us to obtain a posterior mean estimate of the gcp:
ˆgcp :=
1
|X|
∑
x∈X
xL(x) (12)
The estimated standard error is:
sˆe :=
√
1
|X|
∑
x∈X
(x− ˆgcp)2L(x). (13)
In order to compute p-values, we apply a T-test to the statistic S(0).
8 LCV model violations
In this section, we define partial genetic causality without making LCV (or other) model assumptions
and characterize the type of LCV model violation that causes LCV to produce false positives and
bias. There are two classes of LCV model violations: independence violations and proportionality
violations. Roughly, independence violations involve a violation of the independence assumption
between mediated effects (pi) and direct effects (γ) while still satisfying a key proportionality
condition related to the mixed fourth moments; as a result, independence violations are not expected
to cause LCV to produce false positives. Proportionality violations, on the other hand, violate this
proportionality condition and are potentially more problematic. In order to make this characterization,
it is necessary to define partial genetic causality in a more general setting, without assuming the
LCV model. Partial genetic causality is defined in terms of the correlated genetic component of
the bivariate SNP effect size distribution, which generalizes the shared genetic component modeled
by LCV; unlike the shared genetic component, the correlated genetic component does not have
proportional effects on both traits (but merely correlated effects).
8.1 Definition of partial genetic causality without LCV model assumptions
Let A = (α1, α2) be the bivariate distribution of marginal effect sizes, normalized to have zero mean
and unit variance. First, we define an even genetic component of A as a distribution T = (t1, t2) that
is independent of its complement A− T and that satisfies a mirror symmetry condition:
(t1, t2) ∼ (−t1, t2) ∼ (t1,−t2). (14)
Equivalently, the density function of T is an even function of both variables. Note that an even
genetic component does not contribute to the genetic correlation. In order to define the “correlated
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genetic component,” we would like to define a maximal even component, i.e. an even component that
explains the largest possible amount of heritability for both traits. However, if A follows a Gaussian
distribution, then there is no maximal even component: instead, the even genetic component that
maximizes the proportion of trait 1 heritability explained fails to maximize the proportion of trait 2
heritability explained. This fact is related to the observation that the LCV model is non-identifiable
when the effect size distribution for L follows a Gaussian distribution, and only when it follows a
Gaussian distribution.1 Generalizing this result, we conjecture that there exists an even component
that is maximal up to a Gaussian term. More precisely, there exists a maximal even component
T ∗ = (t∗1, t
∗
2) such that for any even component T = (t1, t2), there exists a (possibly degenerate)
Gaussian random variable Z = (z∗1 , z
∗
2) independent of T
∗ such that T ∗ + Z is an even component
and E((t∗1 + z1)
2) ≥ E(t21) and E((t∗2 + z2)2) ≥ E(t22).
We define the correlated genetic component S = (s1, s2) as the complement of the maximal even
component and the Gaussian term. Trait 1 is defined as partially genetically causal for trait 2 if
E(s21) > E(s
2
2), and vice versa. We may also define the genetic causality proportion using main text
equation (1), substituting E(s2k) for q
2
k. However, the interpretation of the gcp is not as clear in this
more general setting. Note that the correlated genetic component may be identically 0, for example if
A is bivariate Gaussian or if A itself is an even component; in both cases, there is no partial causality,
and the genetic causality proportion is undefined. In practice, if the correlated genetic component is 0
or nearly 0, LCV will produce null p-values and low, noisy gcp estimates.
8.2 Independence violations and proportionality violations
The LCV model assumption is equivalent to the statement that the correlated genetic component
is equal to a shared genetic component: S = (q1pi, q2pi), for some random variable pi and fixed
parameters q1, q2 such that ρg = q1q2. This assumption enables an inference approach based on
mixed fourth moments because it implies that the mixed fourth moments of the correlated component
are proportional to the respective variances:
E(s1s2s
2
k) ∝ E(s2k), (15)
where under the LCV model, the proportionality constant is q1q2E(pi4). One form of LCV model
violation arises when S is not a shared genetic component, but (15) still holds. Intuitively, this type
of violation arises as a result of non-independence between mediated effects (pi) and direct effects
(γ), causing “noise” from the direct effects to be incorporated into the correlated component, and we
call such violations independence violations; genetic architectures that violate the proportionality
condition we call proportionality violations. In the presence of an independence violation, we obtain
the following moment condition, generalizing main text equation (2):
E(α1α2α
2
k) = cE(s
2
k) + 3ρg (16)
where c is a proportionality constant. In particular, if E(s21) = E(s
2
2) (no partial causality), then
E(α1α
3
2) = E(α2α
3
1), and LCV is expected to produce well-calibrated p-values. Conversely, under
a proportionality violation, LCV is expected to produce inflated p-values under the null.
However, the interpretation of the gcp is not as clear in this more general setting; in particular, a gcp
of 1 implies that every SNP affecting trait 1 also affects trait 2, but not proportionally. Note that
the correlated genetic component may be identically 0, for example if A is bivariate Gaussian or if
A itself is an even genetic component; in both cases, there is no partial causality, and the genetic
causality proportion is undefined. In practice, if the correlated genetic component is 0 or nearly 0,
LCV will produce null p-values and low, noisy gcp estimates.
9 Extended Simulations
9.1 Existing Mendelian Randomization methods
Two-sample MR. As described in ref. 22, we ascertained significant SNPs (p < 5 × 10−8, χ2
test) for the exposure and performed an unweighted regression, with intercept fixed at zero, of the
estimated effect sizes on the outcome with the estimated effect sizes on the exposure (in practice,
a MAF-weighted and LD-adjusted regression is often used; in our simulations, all SNPs had equal
MAF, and there was no LD). To assess the significance of the regression coefficient, we estimated
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the standard error as se =
√
1
K
∑K
k=1 β¯
2
k2∑K
k=1 βˆ
2
k1
, where β¯k2 is the kth residual, N2 is the sample size in the
outcome cohort, and K is the number of significant SNPs. This estimate of the standard error allows
the residuals to be overdispersed compared with the error that is expected from the GWAS sample
size. To obtain p values, we applied a two-tailed t-test to the regression coefficient divided by its
standard error, with K − 1 degrees of freedom.
MR-Egger. As described in ref. 17, we ascertained significant SNPs for the exposure and coded
them so that the alternative allele had a positive estimated effect on the exposure. We performed
an unweighted regression with a fitted intercept of the estimated effect sizes on the outcome on the
estimated effect sizes on the exposure. We assessed the significance of the regression using the same
procedure as for two-sample MR, except that the t-test used K − 2 rather than K − 1 degrees of
freedom.
Bidirectional MR. We implemented bidirectional mendelian randomization in a manner similar to
ref. 9. Significant SNPs were ascertained for each trait. If the same SNP was significant for both
traits, then it was assigned only to the trait where it ranked higher (if a SNP ranked equally high for
both traits, it was excluded from both SNP sets). The Spearman correlations r1, r2 between the z
scores for each trait was computed on each set of SNPs, and we applied a χ21 test to
χ2 =
1
1
K1−3 +
1
K2−3
(atanh(r1)− atanh(r2))2, (17)
where Kj is the number of significant SNPs for trait j. In ref. 9, the statistics atanh(rj) were also
used, but a relative likelihood comparing several different models was reported instead of a p-value.
We chose to report p-values for Bidirectional MR in order to allow a direct comparison with other
methods.
Application of MR to real data. For our applications of MR and related methods to real data,
we selected genetic instruments using a greedy pruning procedure. We ranked all genome-wide
significant SNPs for the exposure (p < 5× 10−8) by χ2 statistic. Iteratively, we removed all SNPs
within 1cM of the first SNP in the list, obtaining a set of independent lead SNPs separated by at least
1cM. We confirmed using an LD reference panel that our 1cM window was sufficient to minimize
LD among the set of retained SNPs. We applied each MR method as described above; in particular,
we performed unweighted regressions for MR and MR-Egger.
9.2 Simulations involving LCV model violations
In order to investigate potential limitations of our approach, we performed null and causal simulations
under genetic architectures that violate LCV model assumptions. There are two classes of LCV
model violations: independence violations and proportionality violations (see LCV model violations).
Roughly, independence violations involve a violation of the independence assumption between (1)
mediated effects (pi) and (2) direct effects (γ) while still satisfying a key proportionality condition
related to the mixed fourth moments; as a result, independence violations are not expected to
cause LCV to produce false positives. Proportionality violations, on the other hand, violate this
proportionality condition and are potentially more problematic. A representative example of an
independence violation is a bivariate Gaussian mixture model where one of the mixture components
generates imperfectly correlated effect sizes on the two traits. These SNPs underlying this mixture
component can be viewed as having both an effect on L and also a residual effect on the two traits
directly, in violation of the independence assumption. First, we performed null simulations under a
Gaussian mixture model with a nonzero genetic correlation. These simulations were similar to the
simulations reported in Figure 2b, except that the correlated SNP effect sizes (1% of SNPs) were
drawn from a bivariate normal distribution with correlation 0.5 (explaining 20% of heritability for
each trait; in Figure 2b, these effects were perfectly correlated). Similar to Figure 2b, LCV and
bidirectional MR produced p-values that were well-calibrated, while MR and MR-Egger produced
inflated p-values (Figure 4a). Second, similar to Figure 2c, we included differential polygenicity
between the two traits, finding that differential polygenicity caused all existing methods including
bidirectional MR, but not LCV, to produce false positives (Figure 4b). Third, similar to Figure 2d, we
included differential power between the two traits, again finding that LCV produced well-calibrated
p-values while existing methods produced false positives (Figure 4c).
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Figure 4: Null and causal simulations with no LD and LCV model violations. We report the positive
rate (α = 0.05 for null simulations, α = 0.001 for causal simulations) for two-sample MR, MR-
Egger, Bidirectional MR and LCV. Panels (a)-(c) correspond to Gaussian mixture model extensions
of the models in Figure 2b-d. Panels (f) and (g) correspond to causal analogues of the models in
panels (a) and (d), respectively. We also display scatterplots illustrating the bivariate distribution of
true SNP effect sizes on the two traits. (a) Null simulation with nonzero SNP effects drawn from a
mixture of Gaussian distributions; one mixture component has correlated effects on each trait. (b)
Null simulation with SNP effects drawn from a mixture of Gaussian distributions, and differential
polygenicity between the two traits. (c) Null simulation with SNP effects drawn from a mixture
of Gaussian distributions, and unequal power between the two traits. (d) Null simulation with two
intermediaries having different effects on each trait. (e) Null simulation with two intermediaries
having different effects on each trait and unequal polygenicity for the two intermediaries. (f) Causal
simulation with SNP effects drawn from a mixture of Gaussian distributions; all SNPs affecting trait 1
also affect trait 2, but the relative effect sizes were noisy. (g) Causal simulation with an additional
genetic confounder (i.e. a second intermediary) mediating part of the genetic correlation. Results for
each panel are based on 1000 simulations.
A representative example of a proportionality violation is a model in which two intermediaries L1 and
L2 have different effect sizes on the two traits, and L1 and L2 also have unequal polygenicity. First,
for comparison purposes, we considered a model with two intermediaries with equal polygenicity;
2% of SNPs were causal for each intermediary, and 4% of SNPs were causal for each trait exclusively.
Because this model implies only an independence violation, we expected that LCV would not produce
false positives. Indeed, LCV produced well-calibrated p-values (Figure 4d). Similar to Figure 2b
and Figure 4a, Bidirectional MR also produced well-calibrated p-values, while MR and MR-Egger
produced false positives. Second, we shifted the polygenicity of the two intermediaries in opposite
directions: 1% of SNPs were causal for L1 and 8% of SNPs were causal for L2, resulting in a
proportionality violation. We expected that LCV would produce false positives, as the intermediary
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Figure 5: Mean gcp estimates in simulations with LCV model violations (error bars show standard
deviations; based on 1000 simulations). (a) Null simulation with two intermediaries having possibly
unequal polygenicity. The two intermediaries had either a slightly, moderately, or highly heterogenous
effect on the two traits; that is, when heterogeneity was high, intermediary 1 had a much larger effect
on trait 1 while intermediary 2 had a much larger effect on trait 2. Then, we specified a certain
difference in polygenicity between the two traits (measured by the proportion of causal SNPs). (b)
Casual simulation with an additional latent confounder. The latent confounder explained either a low,
medium or high proportion of the genetic correlation. We varied the polygenicity of the confounder
and of the causal trait, such that a 16x difference in polygenicity indicates that 16x more SNPs were
causal for the causal trait than for the genetic confounder.
with lower polygenicity would disproportionately affect the mixed fourth moments. Indeed, LCV (as
well as other methods) produced false positives, indicating that proportionality violations cause LCV
to produce false positives (Figure 4e). We investigated the gcp estimates produced by LCV in these
simulations, finding that LCV produced low gcp estimates ( ˆgcp ≈ 0.5; Figure 5a). We varied the
difference in polygenicity as well as the difference in the relative effect sizes of the two intermediaries,
finding that extreme parameter settings (e.g., a 32× difference in polygenicity in conjunction with a
25× difference in the relative effect sizes of L1 and L2) were required to cause LCV to produce high
gcp estimates (gcp > 0.6; Figure 5a). Thus, proportionality violations of LCV model assumptions
can cause LCV (and other methods) to produce false positives, but genetic causality remains the most
parsimonious explanation for high gcp estimates.
Finally, we performed (fully) causal simulations under LCV model violations. First, we simulated an
independence violation by specifying a Gaussian mixture model where every SNP affecting trait 1
also affected trait 2, but the relative effect sizes were noisy (Figure 4f). Sample size and polygenicity
were similar to Figure 3a (4× lower sample size than Figure 4a). As expected, LCV had lower power
to detect a causal effect than in Figure 3a, although it still had moderately high power. Second, we
simulated a proportionality violation by specifying both a causal effect (corresponding to L1) and an
additional genetic confounder (corresponding to L2) (Figure 4g). LCV had lower power to detect a
causal effect than in Figure a, although it still had high power.
In summary, we determined in null simulations that independence violations do not cause LCV to
produce false positives; in addition, these simulations recapitulated the limitations of existing methods
that we observed in simulations under the LCV model. Proportionality violations caused LCV (as
well as existing methods) to produce false positives; however, extreme values of the simulation
parameters were required in order for LCV to produce high gcp estimates. In causal simulations, we
determined that both independence and proportionality violations lead to reduced power for LCV
(and other methods), as well as downwardly biased gcp estimates for LCV.
ρ p < .05 p < .001 Mean χ2 Mean ˆgcp ˆgcp std dev RMS σˆ Zh
a Zero genetic correlation 0 0 0 0.32 -0.00 0.11 0.55 8
b Low genetic correlation 0.1 0.009 0 0.58 0.00 0.14 0.29 8.5
c Default parameter values 0.2 0.058 0.003 1.09 -0.00 0.07 0.08 8.6
d High genetic correlation 0.4 0.067 0.004 1.2 -0.00 0.1 0.11 8
e Very high genetic correlation 0.8 0.058 0.002 1.13 -0.00 0.21 0.24 5.8
17
f Uncorrelated pleiotropic effects 0.2 0.054 0.001 1.06 -0.00 0.08 0.09 8.7
g Differential polygenicity 0.2 0.062 0.002 1.1 -0.01 0.08 0.08 10
h Very different polygenicity 0.2 0.067 0.004 1.19 -0.01 0.1 0.1 11.2
i Low N1 0.2 0.063 0.004 1.14 0.01 0.12 0.13 5
j Very low N1 0.2 0.228 0.132 11.2 0.11 0.35 0.33 1.4
k Different heritability 0.2 0.061 0.005 1.7 0.00 0.09 0.1 6.5
l High phenotypic correlation 0.2 0.057 0.002 1.12 0.00 0.07 0.08 8.7
m Zero phenotypic correlation 0.2 0.057 0.005 1.1 0.00 0.07 0.08 8.6
n Uncorrelated pleiotropic effects 0 0.001 0 0.3 0.00 0.14 0.52 8
o Differential polygenicity 0 0 0 0.31 -0.02 0.12 0.55 9.8
p Very different polygenicity 0 0.001 0 0.31 -0.05 0.14 0.52 11.4
q Low N1 0 0.001 0.001 0.31 0.00 0.14 0.52 5
r Very low N1 0 0.272 0.216 46.4 0.27 0.32 0.39 1.4
s Different heritability 0 0 0 0.28 -0.00 0.11 0.55 6.3
t Causal 0.2 0.965 0.94 258 0.76 0.12 0.16 8.6
u Partially causal 0.2 0.706 0.347 12.9 0.56 0.15 0.24 10
v Low N1 0.2 0.852 0.768 66 0.65 0.17 0.2 5.1
w Very low N1 0.2 0.452 0.378 102 0.39 0.35 0.35 1.4
x Low N2 0.2 0.843 0.714 40.8 0.60 0.18 0.21 8.7
y Weak causal effect 0.1 0.422 0.104 6.36 0.49 0.18 0.32 8.7
z Y1 less polygenic 0.2 0.997 0.996 7331 0.90 0.08 0.07 3.6
aa Y1 more polygenic 0.2 0.155 0.004 2.39 0.28 0.2 0.47 13.3
bb Y1 infinitessimal 0.2 0.012 0 0.7 0.07 0.2 0.5 14.2
Table 3: Null and non-null simulations with LD. Proportion of simulations (out
of n = 5000) with LCV p-value for partial causality less than 0.05 and less than
0.001; mean χ2 statistic; mean ˆgcp (in each case, standard error is less than 0.01);
empirical standard deviation of ˆgcp; root mean squared estimated standard error;
mean heritability Z-score for trait 1. Simulations a-s are null (gcp = 0), and
simulations t-bb are non-null. (a-e) Different values of the genetic correlation
(ρ). When the genetic correlation is zero or near-zero, we observe conservative
p-values and overestimates of the ˆgcp standard error. (f) Uncorrelated pleiotropic
effects: 0.3% of SNPs affect both traits with independent effect sizes. (g-h)
Differential or very different polygenicity: 0.2% and 0.8% of SNPs, or 0.1% and
1.6% of SNPs respectively, have direct effects on each trait. (i-j) Low or very low
sample size for trait 1: eitherN1 = 20k orN1 = 4k respectively, andN2 = 100k.
(k) Different heritability: h21 = 0.1 and h22 = 0.5. (l) High phenotypic correlation
of 0.4, compared with ρ = 0.2. (m) Zero phenotypic correlation. (n) Uncorrelated
pleiotropic effects: 0.3% of SNPs affect both traits with independent effect sizes.
(o-p) Differential or very different polygenicity: 0.2% and 0.8% of SNPs, or 0.1%
and 1.6% of SNPs respectively, have direct effects on each trait. (q-r) Low or
very low sample size for trait 1: either N1 = 20k or N1 = 4k respectively, and
N2 = 100k. (s) Different heritability: h21 = 0.1 and h22 = 0.5. (t) Causal. (u)
Partially causal (gcp = 0.5). (v-w) Causal, with low or very low sample size
for the causal trait (N1 = 20k or N1 = 4k, and N2 = 100k). (x) Causal, with
low sample size in the downstream trait (N2 = 20k, N1 = 100k). (y) Weak
causal effect (0.1 rather than 0.25). (z-bb) Varying polygenicity for the causal
trait: instead of 0.5% of SNPs causal, either 0.05%, 5%, or 100% of SNPs causal
for z-bb respectively.
9.3 Simulations with LD
We performed simulations with LD to assess the robustness of LCV; we note that LD can potentially
affect the performance of our method, which uses a modified version of LD score regression8, 21
to normalize effect size estimates and to estimate genetic correlations. LD was computed using
M = 596k common SNPs in N = 145k samples of European ancestry from the UK Biobank
interim release.23 Unlike our simulations with no LD, these simulations also included sample overlap.
Because existing methods exhibited major limitations in simulations with no LD (Figure 2), we
restricted these simulations to the LCV method.
First, we performed null simulations to assess calibration. We chose a set of default parameters similar
to Figure 2b and varied each parameter in turn. In particular, similar to Figure 2, these simulations
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ρ p < .05 p < .001 Mean χ2 Mean ˆgcp ˆgcp std dev RMS σˆ Zh
a Default parameter values 0.2 0.034 0 0.9 0.00 0.05 0.06 16.7
b Zero genetic correlation 0 0.001 0 0.31 -0.00 0.11 0.55 15.3
c Very high genetic correlation 0.8 0.033 0.002 0.94 -0.00 0.11 0.43 10.9
d Uncorrelated pleiotropic effects 0.2 0.032 0.000 0.87 -0.00 0.06 0.09 16.6
e Differential polygenicity 0.2 0.034 0.002 0.86 -0.00 0.05 0.07 19.3
f Low N1 0.2 0.042 0.002 0.9 0.00 0.1 0.12 8.7
g Very low N1 0.2 0.254 0.16 19.96 0.08 0.35 0.32 2.2
h Causal 0.2 0.968 0.943 257.17 0.76 0.11 0.16 16.5
i Partially causal 0.2 0.765 0.369 12.54 0.57 0.15 0.23 19.2
Table 4: Simulations with LD using constrained-intercept LD score regression to estimate the
heritability. This heritability estimation method is less noisy than variable-intercept LD score
regression but can produce biased estimates on real data due to population stratification and cryptic
relatedness.21 Proportion of simulations (out of n = 2000) with p-value for partial causality less
than .05 and less than .001; mean χ2 statistic for partial causality; mean ˆgcp; standard deviation
of gcp estimates; root-mean squared estimated standard error. Simulations a-f are null (gcp = 0),
and simulations g-h are non-null. (a) Realistic simulation parameters (see Methods). (b) Genetic
correlation ρ = 0. (c) Genetic correlation ρ = 0.75. (d) Uncorrelated pleiotropic effects in addition
to a genetic correlation: 50% of SNPs with direct (non-mediated) effects on each trait are shared
between the two traits. (e) Differential polygenicity: 0.2% and 0.05% of SNPs have direct effects
on each trait. (f) Different sample size: N1 = 1000k and N2 = 500k. (g) Different sample size:
N1 = 20k and N2 = 500k. (h) Full genetic causality: gcp = 1, with causal effect equal to the genetic
correlation (0.25). (i) Partial genetic causality: gcp = 0.5.
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Figure 6: Unbiasedness of posterior mean gcp estimates in simulations with LD and random true gcp
values. Estimated values of gcp were binned and averaged, and mean true values of gcp are plotted
for each bin, with standard errors. Points above the line indicate that gcp estimates were downwardly
biased (toward -1). (a) Ascertained simulations (43%) with significant genetic correlation (p < 0.05)
and evidence for partial causality (p < 0.001). Only bins with count at least 10 are plotted. (b) All
10k simulations.
included uncorrelated pleiotropy, genetic correlations, differential polygenicity between the two
traits, and differential power between the two traits (Table 3a-m). LCV produced approximately
well-calibrated or conservative false positive rates. Slight inflation was observed due to noise in our
heritability estimates (Table 3c-m); proper calibration was restored by using constrained-intercept LD
score regression21 (resulting in more precise heritability estimates) (Table 4a-f). To avoid problems
with noisy heritability estimates, we restrict our analyses of real traits to data sets with highly
significant heritability estimates (Z score for nonzero h2 = Zh > 7).
Second, we performed causal simulations to assess power. We chose a set of default parameters
similar to our null simulations, finding that LCV was well-powered (Table 3t), although its power
was lower than in simulations with no LD (Figure a). We varied each parameter in turn, finding
that power was reduced when we reduced the sample size, increased the polygenicity of the causal
trait, reduced the causal effect size, or simulated a partially causal rather than fully causal genetic
architecture (Table 3u-bb), similar to simulations with no LD (Figure b-f). These simulations indicate
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that LCV is well-powered to detect a causal effect for large GWAS under most realistic parameter
settings, although its power does depend on genetic parameters that are difficult to predict.
Third, to assess the unbiasedness of gcp posterior mean (and variance) estimates, we performed
simulations in which the true value of gcp was drawn uniformly from [−1, 1] (corresponding to the
prior that LCV uses to compute its posterior mean estimates). We expected posterior-mean estimates
to be unbiased in the Bayesian sense that E(gcp| ˆgcp) = ˆgcp (which differs from the usual definition
of unbiasedness, that E( ˆgcp|gcp) = gcp).? Thus, we binned these simulations by ˆgcp and plotted the
mean value of gcp within each bin (Figure 6). We determined that mean gcp within each bin was
concordant with ˆgcp. In addition, the root mean squared error was 0.15, approximately consistent
with the root mean posterior variance estimate of 0.13 (Table 5).
In summary, we confirmed using simulations with LD that LCV produces well-calibrated false
positive rates under a wide range of realistic genetic architectures; some p-value inflation was
observed when heritability estimates were noisy, but false positives can be avoided in analyses of
real traits by restricting to traits with highly significant heritability (Zh > 7). We also confirmed that
LCV is well-powered to detect a causal effect under a wide range of realistic genetic architectures,
and produces unbiased posterior mean estimates of the gcp.
Regression coefficient (std err) RMSE RMPV
Ascertained simulations (43%) 0.97 (.004) 0.15 0.13
All simulations 1.00 (.005) 0.24 0.20
Table 5: Unbiasedness of estimated gcp and standard error in simulations with random true parameter
values, using real LD. We drew random values of gcp (and ρ) from a Unif(−1, 1) distribution and
compared true and estimated values of gcp, either for all 10k simulations or for a subset (43%) of
simulations in which the genetic correlation was nominally significant p < 0.05 and the evidence for
partial causality was strong (p < 0.001). We report the regression coefficient of true on estimated
gcp values with standard error, as well as the root mean squared error and the root mean posterior
variance estimate.
9.4 Simulation details
In order to simulate summary statistics with no LD, first, we chose causal effect sizes for each SNP
on each trait according to the LCV model. The causal effect size vector for trait k was
βk =
h2k
M
(qkpi + γk), (18)
where in all simulations except for Figure 4, qk was a scalar, and pi and γk were 1 ×M vectors.
In Figure 4, qk was a 1× 2 vector and pi was a 2×M matrix. Entries of pi were drawn from i.i.d.
point-normal distribution with mean zero, variance 1, and expected proportion of causal SNPs equal
to ppi. Entries of γk were drawn from i.i.d. point-normal distributions with expected proportion
of causal SNPs equal to pγk ; we modeled colocalization between non-mediated effects by fixing
some expected proportion of SNPs pγ1,2 < min(pγ1 , pγ2) as having nonzero values of both γ1 and
γ2. Then, we centered and re-scaled the nonzero entries of pi and γk, so that they had mean 0 and
variance 1 and 1− q2k, respectively.
For simulations in Figure 4, effect sizes were drawn from a mixture of Normal distributions: there
was a point mass at (0,0); a component with σ21 = 0, σ
2
2 6= 0; a component with σ21 6= 0, σ22 = 0; and
a component with σ21 6= 0, σ22 6= 0, σ12 =
√
σ21σ
2
2 .
Second, we simulated summary statistics as
βˆk∼N(βk, 1
Nk
I), (19)
where βk is the vector of true causal effect sizes for trait k and Nk is the sample size for trait k. When
we ran LCV on these summary statistics, we used constrained-intercept LD score regression rather
than variable-intercept LD score regression both to normalize the effect estimates21 and to estimate
the genetic correlation,8 with LD scores equal to one for every SNP.
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In simulations with LD, we first simulated causal effect sizes for each trait in the same manner as
simulations with no LD. Then, we obtained summary statistics in one of two ways, either using real
genotypes or using real LD only.
For other simulations, we simulated summary statistics without first simulating phenotypic values,
using the fact that the sampling distribution of Z-scores is approximately:32
Z∼N(
√
NRβ,R), (20)
where R is the LD matrix and β is the vector of true effect sizes. We estimated R from the
N = 145k UK Biobank cohort using plink with an LD window size of 2Mb (M = 596k), which
we converted into a block diagonal matrix with 1001 blocks. The number 1001 was chosen instead
of the number 1000 so that the boundaries of these blocks would not align with the boundaries of
our 100 jackknife blocks; the use of blocks allowed us to avoid diagonalizing a matrix of size 596k,
while not significantly changing overall LD patterns (there are ∼50, 000 independent SNPs in the
genome, and 1001 << 50, 000). Because the use of a 2Mb window causes the estimated LD matrix
to be non-positive semidefinite (even after converting it into a block diagonal matrix), each block was
converted into a positive semidefinite matrix by diagonalizing it and removing its negative eigenvalues:
that is, we replaced each block A = V ΣV T with the matrix B, where B = V max(0,Σ)V T . Then,
because the removal of negative eigenvalues causes B′ to have entries slightly different from one, we
re-normalized each block: C = D−1/2BD−1/2, where D is the diagonal matrix corresponding to
the diagonal of B. Even though the diagonal elements of B are close to 1 (mostly between 0.99 and
1.01), this step is important to obtain reliable heritability estimates using LD score regression because
otherwise the diagonal elements of the LD matrix will be strongly correlated with the LD scores
(r2 ≈ 0.5) and the heritability estimates will be upwardly biased, especially at low sample sizes.
We concatenated the blocks C1, ..., C1001 to obtain a positive semi-definite block-diagonal matrix
R′. We also computed and concatenated the matrix square root of each block. In order to obtain
samples from a Normal distribution with mean R′β and variance 1NR
′, we multiplied a vector having
independent standard normal entries by the matrix square root of R′ and added this noise vector to the
vector of true marginal effect sizes, R′β. We computed LD scores directly from R. For simulations
with sample overlap, the summary statistics were correlated between the two GWAS: the correlation
between the noise term in the estimated effect of SNP i on trait 1 and the estimated effect of SNP j
on trait 2 was R′ijρtotalNshared/
√
N1N2, which is the amount of correlation that would be expected if
the total (genetic plus environmental) correlation between the traits is ρtotal.8
10 Discussion of additional trait pairs
We briefly discuss several other trait pairs with significant evidence of partial genetic causality,
including novel results and results that have previously been reported (Table 2).
• We identified four traits with evidence for a fully or partially genetically causal effect on
hypertension (Table 2), which is genetically correlated with MI (ρˆg = 0.49(0.10)). These
included genetically causal effects of BMI, consistent with the published literature,9, 34 as
well as triglycerides and HDL. The genetically causal effect of HDL indicates that there
exist major metabolic pathways affecting hypertension with little or no corresponding effect
on MI. The positive partially genetically causal effect of reticulocyte count, which had a low
gcp estimate ( ˆgcp = 0.41(0.13)), is likely related to the substantial genetic correlation of
reticulocyte count with triglycerides (ρˆg = 0.33(0.05)) and BMI (ρˆg = 0.39(0.03)).
• We detected evidence for a fully or partially genetically causal effect of triglycerides on
five cell blood traits: mean cell volume, platelet distribution width, reticulocyte count,
eosinophil count and monocyte count (Table 1). These results highlight the pervasive effects
of metabolic pathways, which can induce genetic correlations with cardiovascular pheno-
types. For example, shared metabolic pathways may explain the high genetic correlation of
reticulocyte count with MI (ρˆg = 0.31(0.06)) and hypertension (ρˆg = 0.27(0.04)).
• There was evidence for a negative fully or partially genetically causal effect of balding on
number of children in males. Two possible explanations are shared pathways involving
androgens41 and sexual selection against early balding.
• There was evidence for a positive fully or partially genetically causal effect of BMI on
triglycerides, consistent with results using MR34 and bidirectional MR.9 There was also
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evidence for a positive genetically causal effect of LDL on the self-reported high cholesterol
phenotype, consistent with LDL cholesterol representing one component of this compound
phenotype.
• There was evidence for fully or partially genetically causal effects of several traits on various
platelet phenotypes: large negative effects on platelet count for platelet distribution width
and platelet volume, and effects of triglycerides and HDL on platelet distribution width.
• It has been suggested that height has a causal effect on educational attainment.36 While our
results support a partially genetically causal effect, the low gcp estimate ( ˆgcp = 0.33(0.10))
suggests shared developmental pathways rather than direct causality, highlighting the benefit
of our non dichotomous approach to causal inference. There was a similar result for age at
menarche and height, which was previously reported using Bidirectional MR.9
• A recent study reported genetic correlations between various complex traits and number
of children in males and females.40 We identified only one trait (balding in males) with
a fully or partially causal effect on number of children (negative effect on number of
children in males). (Two possible explanations are shared pathways involving androgens41
and sexual selection against early balding.) For college education, which has a strong
negative genetic correlation with number of children (ρˆg = −0.31(0.07) and −0.26(0.06)
in males and females respectively), we obtained low gcp estimates with low standard errors
( ˆgcp = 0.00(0.09) and ˆgcp = 0.04(0.21) respectively), providing evidence against causality.
Thus, a genetic correlation with number of children does not imply a causal effect. This
result does not contradict the conclusion of reference 40 that complex traits are under natural
selection, as natural selection produces a change in the mean value of a trait even if the trait
is non-causally correlated with fitness.42
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